Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

Epidemiology and Factors Affecting Mortality of Hospitalized Patients with Disseminated Intravascular Coagulation in the United States

Arya Mariam Roy, MD, Manojna Konda, MD, Akshay Goel, MD, Appalanaidu Sasapu, MD

Blood (2019) 134 (Supplement_1): 2404.

https://doi.org/10.1182/blood-2019-132071

Published: 2019

Journal Articles

Nascent Transcript and Single Cell Rnaseq Analysis Defines the Mechanism of Action of the LSD1 Inhibitor INCB059872 in Myeloid Leukemia

Gretchen Johnston, Haley E. Ramsey, PhDMSc, Kristy Stengel, PhD, Shilpa Sampathi, PhD, Pankaj Acharya, PhD, Maria Arrate, MSc, Matthew C. Stubbs, PhD, Timothy Burn, PhD, Scott Hiebert, PhD, Michael R. Savona, MD

Blood (2019) 134 (Supplement_1): 2509.

https://doi.org/10.1182/blood-2019-130458

Published: 2019

Journal Articles

Phase I/II, Open-Label, Adaptive Study of Oral Bruton Tyrosine Kinase Inhibitor PRN1008 in Patients with Relapsed/Refractory Primary or Secondary Immune Thrombocytopenia

David J. Kuter, Ralph V. Boccia, MD, Eun-Ju Lee, MD, Merlin Efraim, MD, Nikolay Tzvetkov, MD, Jiri Mayer, MD, Marek Trněný, MD, Milan Kostal, MD, Roman Hajek, MD, Vickie McDonald, MD, Olga Bandman, MD, Regan Burns, Ann Neale, Dolca Thomas, MD, Nichola Cooper, MD MRCP

Blood (2019) 134 (Supplement_1): 87.

https://doi.org/10.1182/blood-2019-122336

Published: 2019

Journal Articles

Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms

Shaun P. Jackson, Roxane Darbousset, Simone M. Schoenwaelder

Blood (2019) 133 (9): 906–918.

https://doi.org/10.1182/blood-2018-11-882993

Published: 2019

Journal Articles

Hyperactivation of Plasmin Following Severe Burn Is Associated with Systemic Inflammation and Coagulopathy

Breanne HY Gibson, BSc, Patrick R Keller, BA, BM, Stephanie N Moore-Lotridge, BSc, J. Blair Summitt, MD, Jonathan G Schoenecker, MD PhD

Blood (2018) 132 (Supplement 1): 3780.

https://doi.org/10.1182/blood-2018-99-116904

Published: 2018

Journal Articles

Beta3-Adrenergic Blockade Restores Erythropoietic Homeostasis in Anemia of Critical Illness

Kuzhali Muthumalaiappan, PhD, Shirin Hasan, PhD, Ameet Kini, MD PhD, Pravesh Saini, BS, Julia Walczak, Anthony J Baldea, MD

Blood (2018) 132 (Supplement 1): 3615.

https://doi.org/10.1182/blood-2018-99-112194

Published: 2018

Journal Articles

Association between Patient-Reported Outcomes and Physical Activity Measured on the Apple Watch in Patients with Hematological Malignancies

Carrie A Thompson, MD, Paul Novotny, Jeff A. Sloan, PhD, Alicia Bartz, Kathleen Yost, PhD

Blood (2017) 130 (Supplement 1): 2179.

https://doi.org/10.1182/blood.V130.Suppl_1.2179.2179

Published: 2017

Journal Articles

Disseminated Intravascular Coagulation and Annual Trends in in-Hospital Outcomes Based on Etiology from 2002 to 2014

Saqib Abbasi, MD, Prateek Patibandla, MBBS, Gautam Kishore Valecha, MBBS, Alisa Sokoloff, MD

Blood (2017) 130 (Supplement 1): 2148.

https://doi.org/10.1182/blood.V130.Suppl_1.2148.2148

Published: 2017

Journal Articles

Use of a Fitness Tracking Device to Monitor Physical Activity and Sleep Patterns during Hospitalization for Hematopoietic Stem Cell Transplant. Results of a Prospective Observational Study

Najla H El Jurdi, MD, Mathew J Cotton, MS, Raisa Pinto, MD, Erin Galloway, RN BSN, Samantha Kolke, RN, BSN, Brenda W. Cooper, MD, Ben K. Tomlinson, MD, Leland Metheny, MD, Ehsan Malek, MD, Nora Nock, PhD, Merle Kolk, Richard Lee, Marcos De Lima, MD, Paolo Caimi, MD

Blood (2017) 130 (Supplement 1): 3446.

https://doi.org/10.1182/blood.V130.Suppl_1.3446.3446

Published: 2017

Journal Articles

Smart niche usage: release its fat and burn it!

Jan Jacob Schuringa

Blood (2017) 129 (10): 1239–1240.

https://doi.org/10.1182/blood-2017-01-761551

Published: 2017

Journal Articles

Incidence of Type II Diabetes Mellitus and Hyperlipidemia in Patients Prescribed Dasatinib or Nilotinib As First or Second Line Therapy for Chronic Myelogenous Leukemia (CML)

Meg Franklin, PharmD, PhD, Leah Burns, MPH, Samuel Perez, BA, Deepak Yerragolam, B. Tech, Dinara Makenbaeva, MD MBA

Blood (2016) 128 (22): 4766.

https://doi.org/10.1182/blood.V128.22.4766.4766

Published: 2016

Journal Articles

LSD1 Inhibition Induces Fetal Hemoglobin Expression and Provides a Novel Therapeutic Approach to Sickle Cell Disease

Blood (2016) 128 (22): 2472.

https://doi.org/10.1182/blood.V128.22.2472.2472

Published: 2016

Journal Articles

Installing FVIII-Specific Tolerance in Hemophilia Via Engagement of the Aryl Hydrocarbon Receptor By Tryptophan Derivatives

Davide Matino, Marco Gargaro, Giulia Scalisi, Antonella Turco, Francisco Javier Quintana, Paolo Puccetti, Alfonso Iorio, MD PhD, Francesca Fallarino

Blood (2016) 128 (22): 2563.

https://doi.org/10.1182/blood.V128.22.2563.2563

Published: 2016

Journal Articles

Pathological Heterotopic Ossifications in Brain or Spinal Cord Injured Patients: From Ectopic Bone to Hematopoietic Stem Cell Niche Development

Frédéric Torossian, PhD, Bernadette Guerton, Adrienne Anginot, PhD, Nassim Arouche, Laetitia Boutin, Denis Clay, Nathalie Rochet, PhD MD, Christophe Desterke, PhD, Erica Vlachos, Guillaume Genet, Philippe Denormandie, PhD MD, François Genet, PhD MD, Jean-Pierre Levesque, PhD, Jean-Jacques Lataillade, PhD MD, Marie-Caroline Le Bousse-Kerdiles, PhD

Blood (2016) 128 (22): 3889.

https://doi.org/10.1182/blood.V128.22.3889.3889

Published: 2016

Journal Articles

Voruciclib Sensitizes High Risk Diffuse Large B Cell Lymphoma to BCL2 Inhibition Mediated Cell Death and Tumor Regression

Joyoti Dey, PhD MPH, William Kerwin, PhD, Joseph Casalini, BS, Angela Merrell, BS, Marc Grenley, BS, Sally Ditzler, BS, Chantel Dixon, BS, Connor Burns, BS, Alexey V Danilov, MD PhD, Richard Klinghoffer, PhD

Blood (2016) 128 (22): 4167.

https://doi.org/10.1182/blood.V128.22.4167.4167

Published: 2016

Journal Articles

Erythropoietin Resistant Anemia Following Burn Trauma Is in Part Due to Defective Terminal Maturation of Orthochromatic Erythroblasts Influenced By Erythroblast Island Macrophages

Shirin Hasan, Ameet R Kini, MD PhD, Andrea Szilagyi, BS, Peggie Conrad, BSN, RN, Richard L Gamelli, MD FACS, FRCS (Hon), Kuzhali Muthumalaiappan, PhD

Blood (2015) 126 (23): 4776.

https://doi.org/10.1182/blood.V126.23.4776.4776

Published: 2015

Journal Articles

Evaluation of Normal Reference Range of Schistocytes and Burr Cells in Healthy Adults

Mashrafi Ahmed, MD, Ashok R. Patel, MD

Blood (2015) 126 (23): 4540.

https://doi.org/10.1182/blood.V126.23.4540.4540

Published: 2015

Journal Articles

A Phase 1b Study of Birinapant in Combination with 5-Azacitadine in Patients with Myelodysplastic Syndrome Who Are Naïve, Refractory or Have Relapsed to 5-Azacitadine

Gautam Borthakur, MD, James M. Foran, MD, Eunice S. Wang, MD, Amol Rakkar, Hans Minderman, Jennifer Burns, Michael Andreeff, MD PhD, Raoul Tibes, MD PhD

Blood (2015) 126 (23): 93.

https://doi.org/10.1182/blood.V126.23.93.93

Published: 2015

Journal Articles

Preliminary Results of a Phase 2, Open-Label Study of Venetoclax (ABT-199/GDC-0199) Monotherapy in Patients with Chronic Lymphocytic Leukemia Relapsed after or Refractory to Ibrutinib or Idelalisib Therapy

Jeffrey Jones, MD, Anthony R. Mato, MD, Steven Coutre, MD, William Wierda, MD PhD, Michael Y. Choi, MD, Matthew S. Davids, MD, Nicole Lamanna, MD, Paul Barr, MD, Kim Burns, BA, Nicholas Montalvo, MBA, Ming Zhu, PhD, Todd Busman, MS, Jalaja Potluri, MD FACP, Rod A. Humerickhouse, MD PhD, John C. Byrd, MD

Blood (2015) 126 (23): 715.

https://doi.org/10.1182/blood.V126.23.715.715

Published: 2015

Journal Articles

Osteoblast ablation burns out functional stem cells

Meng Zhao, Linheng Li

Blood (2015) 125 (17): 2590–2591.

https://doi.org/10.1182/blood-2015-03-633651

Published: 2015

NARROW

Epidemiology and Factors Affecting Mortality of Hospitalized Patients with Disseminated Intravascular Coagulation in the United States

Nascent Transcript and Single Cell Rnaseq Analysis Defines the Mechanism of Action of the LSD1 Inhibitor INCB059872 in Myeloid Leukemia

Phase I/II, Open-Label, Adaptive Study of Oral Bruton Tyrosine Kinase Inhibitor PRN1008 in Patients with Relapsed/Refractory Primary or Secondary Immune Thrombocytopenia

Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms

Hyperactivation of Plasmin Following Severe Burn Is Associated with Systemic Inflammation and Coagulopathy

Beta3-Adrenergic Blockade Restores Erythropoietic Homeostasis in Anemia of Critical Illness

Association between Patient-Reported Outcomes and Physical Activity Measured on the Apple Watch in Patients with Hematological Malignancies

Disseminated Intravascular Coagulation and Annual Trends in in-Hospital Outcomes Based on Etiology from 2002 to 2014

Use of a Fitness Tracking Device to Monitor Physical Activity and Sleep Patterns during Hospitalization for Hematopoietic Stem Cell Transplant. Results of a Prospective Observational Study

Smart niche usage: release its fat and burn it!

Incidence of Type II Diabetes Mellitus and Hyperlipidemia in Patients Prescribed Dasatinib or Nilotinib As First or Second Line Therapy for Chronic Myelogenous Leukemia (CML)

LSD1 Inhibition Induces Fetal Hemoglobin Expression and Provides a Novel Therapeutic Approach to Sickle Cell Disease

Installing FVIII-Specific Tolerance in Hemophilia Via Engagement of the Aryl Hydrocarbon Receptor By Tryptophan Derivatives

Pathological Heterotopic Ossifications in Brain or Spinal Cord Injured Patients: From Ectopic Bone to Hematopoietic Stem Cell Niche Development

Voruciclib Sensitizes High Risk Diffuse Large B Cell Lymphoma to BCL2 Inhibition Mediated Cell Death and Tumor Regression

Erythropoietin Resistant Anemia Following Burn Trauma Is in Part Due to Defective Terminal Maturation of Orthochromatic Erythroblasts Influenced By Erythroblast Island Macrophages

Evaluation of Normal Reference Range of Schistocytes and Burr Cells in Healthy Adults

A Phase 1b Study of Birinapant in Combination with 5-Azacitadine in Patients with Myelodysplastic Syndrome Who Are Naïve, Refractory or Have Relapsed to 5-Azacitadine

Preliminary Results of a Phase 2, Open-Label Study of Venetoclax (ABT-199/GDC-0199) Monotherapy in Patients with Chronic Lymphocytic Leukemia Relapsed after or Refractory to Ibrutinib or Idelalisib Therapy

Osteoblast ablation burns out functional stem cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only